Biography

Dr. Wu Ke is the Chair and CEO of BravoVax, also President and founder of BravoBio. He has more than 25 years of experiences in biopharm industry and had successfully developed 7 products being approved by CFDA and marketed in China. He also has 20+ applications/granted patents from China or PCT. Before March 2011, he was Executive President of Shanghai Zerun Biotechnology, in charge of management of QA/QC, Manufacture, R&D, Engineering and Maintenance, Regulatory Affairs, Marketing, also extensively experienced in business development, technology transfer, etc. Prior to start Zerun, he was Director of R&D in Wuhan Institute of Biological Products, China National Biotec Group (CNBG), in charge of development of new vaccines and blood products. He holds a PhD degree in Immunology, also alumnus of both China Europe International Business School (CEIBS) and Cheung Kong Graduate School of Business (CKGSB).

---

Research Interest

Pharmaceutical, Biotechnology